The anesthesia & respiratory devices market size in the Middle East & Africa was worth USD 2.01 billion in 2022. It is further estimated to be growing at a CAGR of 8.74% and worth USD 3.06 billion by 2027.
The MEA Anesthesia and respiratory device market are expected to grow due to the increase in the incidence of respiratory disorders, fast urbanization, an increase in the number of surgical procedures, an increase in pollution levels, an increase in the elderly population and an increase in tobacco consumption. Furthermore, factors such as respiratory care device advancements and government assistance for the introduction and approval of these devices are fueling market expansion.
Rising healthcare expenditures and increased demand for therapeutic devices in homecare settings are likely to present attractive potential possibilities for the market. Furthermore, manufacturers' involvement in patient care innovation, such as integrating improved patient monitors, innovative parameters, wireless devices, processes, and integrated IT solutions, is fueling demand. These improvements allowed diverse doctors and anesthesiologists to provide end-users with customized services. In addition, the demand for anesthetic drugs is likely to rise because of the increasing volume of advanced surgical procedures. To meet increased demand, anesthetic administration has been extended to other healthcare staff, previously prohibited.
The rising prevalence of chronic respiratory disorders such as asthma, chronic pulmonary fibrosis, pulmonary hypertension, and occupational lung disease are likely to propel the anesthesia and respiratory devices market forward. An increase in the market for anesthetic and respiratory devices will be fueled by rising spending on healthcare facilities in developing countries. The MEA market for anesthesia and respiratory equipment is further estimated to grow as respiratory disorders in this region and the number of road accidents rises. Long-term market expansion will be aided by the leading important players' increased focus on technological advancements.
The presence of a large pool of undiagnosed population, hazards associated with some therapeutic and diagnostic equipment for newborns, and a low acceptance rate of new technologies due to physician reluctance to treat, are expected to limit the market growth. In addition, high prices for advanced devices, a scarcity of trained workers and technical resources, low penetration of anesthesia and respiratory devices, limited healthcare access, a lack of awareness about respiratory conditions, and long and complex regulatory approval processes for medical devices stifled growth.
This research report on the Middle East and Africa Anaesthesia and Respiratory Devices Market segmented and sub-segmented into the following categories.
By Device:
By Region:
Africa's smallest market size is due to the region's inadequate healthcare infrastructure, volatile political situation, and limited manufacturing capabilities. The Middle East's market size was mostly limited by the region's tiny patient pool and political instability in nations like Syria and Iraq. In Saudi Arabia, the majority of patients are dissatisfied with anesthetic care. In Saudi Arabia, a survey was done in 2018 to assess patient satisfaction and experiences with pre-and postoperative anesthesia. Physicians and nurses in Egypt were ignorant about anesthetic contamination and disposal. The faculty of medicine at Zagazig University and Fayoum University in Egypt did a cross-sectional study in two university hospitals in Egypt to better understand the process of infection management and device contamination in anesthetic practices. As a result, MEA has a small market size in the world.
KEY MARKET PLAYERS:
Leading healthcare companies like Philips Healthcare, OSI Systems, Mindray, GE Healthcare, Draegerwerk AG, Masimo, Getinge Group, Fisher and Paykel, Covidien, Airsep Corp, Alung Technologies Inc, Bomimed Inc, 3M, Carefusion Inc, Astra Zeneca, Invacare, ResMed, Teleflex Inc, and Smiths Medical are playing an important role in the Anaesthesia and Respiratory Devices Market in the Middle East & Africa region.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device
5.1.1 Introduction
5.1.2 Anaesthesia Devices
5.1.2.1 Anaesthesia Machines
5.1.2.2 Anaesthetic Monitors
5.1.2.3 Anaesthetic Vaporizers
5.1.2.4 Analgesic Machines
5.1.2.5 Anaesthetic Masks
5.1.2.6 Anaesthetic Accessories
5.1.3 Respiratory Devices
5.1.3.1 Humidifiers
5.1.3.2 Resuscitators
5.1.3.3 Breathing Circuits
5.1.3.4 Chambers
5.1.3.5 CPAP Devices
5.1.3.6 Masks
5.1.3.7 Oxygen Concentrators
5.1.3.8 Nebulizers
5.1.3.9 Ventilators
5.1.3.10 Inhalers
5.1.3.11 Tracheotomy Tubes
5.1.3.12 Oxygen Cannula
5.1.3.13 Capnographs
5.1.3.14 Spirometers
5.1.5 Y-o-Y Growth Analysis, By Device
5.1.6 Market Attractiveness Analysis, By Device
5.1.7 Market Share Analysis, By Device
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Philips Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 OSI Systems and Mindray
8.3 GE Healthcare
8.4 Draegerwerk AG
8.5 Masimo
8.6 Getinge Group
8.7 Fisher and Paykel
8.8 Covidien
8.9 Airsep Corp.
8.10 Alung Technologies Inc.
8.11 Bomimed Inc.
8.12 3M
8.13 Carefusion Inc.
8.14 Astra Zeneca
8.15 Invacare
8.16 ResMed
8.17 Teleflex Inc.
8.18 Smiths Medical
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
